Joseph Edelman

Affiliations

  • Director at Cerevel Therapeutics Holdings Inc. (CERE), 2024-02-21
  • Large Shareholder, Director at Lianbio (LIAN), 2024-02-20
  • Director at Astria Therapeutics Inc. (ATXS), 2024-02-05
  • Large Shareholder, Director at Solid Biosciences Inc. (SLDB), 2024-01-12
  • Large Shareholder at Verrica Pharmaceuticals Inc. (VRCA), 2023-12-29
  • Large Shareholder, Director at Athira Pharma Inc. (ATHA), 2023-12-29
  • Other at Cargo Therapeutics Inc. (CRGX), 2023-11-14
  • Large Shareholder at Aldeyra Therapeutics Inc. (ALDX), 2023-10-18
  • Large Shareholder at Soleno Therapeutics Inc (SLNO), 2023-09-28
  • Director at Nautilus Biotechnology Inc. (NAUT), 2023-06-21
  • Large Shareholder, Director at Meiragtx Holdings Plc (MGTX), 2023-06-12
  • Large Shareholder, Director at Lyra Therapeutics Inc. (LYRA), 2023-06-02
  • Other at Chembio Diagnostics Inc. (CEMI), 2023-05-01
  • Large Shareholder at Vbi Vaccines Inc (VBIV), 2023-04-06
  • Large Shareholder at Landos Biopharma Inc. (LABP), 2023-01-11
  • Large Shareholder at Acrivon Therapeutics Inc. (ACRV), 2022-11-18
  • Large Shareholder at Quotient Ltd (QTNT), 2022-11-02
  • Large Shareholder at Albireo Pharma Inc. (ALBO), 2022-10-13
  • Large Shareholder at Crinetics Pharmaceuticals Inc. (CRNX), 2022-04-18
  • Large Shareholder at Agile Therapeutics Inc (AGRX), 2021-10-15
  • Large Shareholder at Isoplexis Corp (ISO), 2021-10-14
  • Large Shareholder at Rain Therapeutics Inc. (RAIN), 2021-10-13
  • Large Shareholder at Adma Biologics Inc. (ADMA), 2021-09-30
  • Large Shareholder at Leap Therapeutics Inc. (LPTX), 2021-09-28
  • Large Shareholder at Vyne Therapeutics Inc. (VYNE), 2021-08-18
  • at Arya Sciences Acquisition Corp V (ARYE), 2021-07-13
  • Large Shareholder at Prometheus Biosciences Inc. (RXDX), 2021-03-17
  • at Arya Sciences Acquisition Corp Iv (ARYD), 2021-02-26
  • Large Shareholder at Scynexis Inc (SCYX), 2021-01-27
  • Large Shareholder at Motus Gi Holdings Inc. (MOTS), 2021-01-23
  • Large Shareholder at Athenex Inc. (ATNX), 2020-09-14
  • Large Shareholder at Kadmon Holdings Inc. (KDMN), 2019-11-18
  • Large Shareholder at Dova Pharmaceuticals Inc. (DOVA), 2019-11-16
  • Large Shareholder at Foamix Pharmaceuticals Ltd. (FOMX), 2019-08-06
  • Large Shareholder at Amicus Therapeutics Inc. (FOLD), 2019-02-19
  • Large Shareholder at La Jolla Pharmaceutical Co (LJPC), 2019-01-10
  • Large Shareholder at Corium International Inc. (CORI), 2018-10-15
  • Director at Arya Sciences Acquisition Corp. (ARYA), 2018-10-05
  • Large Shareholder at Zogenix Inc. (ZGNX), 2018-08-14
  • Other at Global Blood Therapeutics Inc. (GBT), 2018-07-25
  • Large Shareholder at Versartis Inc. (VSAR), 2017-09-25
  • Large Shareholder at Acelrx Pharmaceuticals Inc (ACRX), 2017-06-21
  • Large Shareholder at Vbi Vaccines Inc. (VBIV), 2017-03-09
  • Large Shareholder at Aegerion Pharmaceuticals Inc. (AEGR), 2013-09-09
  • Large Shareholder at Repros Therapeutics Inc. (RPRX), 2013-03-20
  • Large Shareholder at Synageva Biopharma Corp (TRMS), 2011-11-09
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
ATHA $17.00 1,058,824 Large Shareholder, Director 3,114,805 2020-09-22 Filing